Literature DB >> 15316806

The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.

Xiang-Jun Chen1, Jian Qiao, Bao-Guo Xiao, Chuan-Zhen Lu.   

Abstract

Myasthenia gravis (MG) is caused by autoantibodies to acetylcholine receptors (AChR). Non-AChR muscle autoantibodies, such as titin antibodies, are present in sera of many MG patients. To study the correlation between titin antibodies and the features of MG, the cDNA segment encoding MGT-30 was amplified and sequenced. The cloned MGT-30 cDNA was expressed in vector pET-30a, and then transfected into E.coli. BL21. We examined titin antibodies in sera of 265 normal subjects, 154 MG patients with different thymic pathology and 48 patients with other neurological diseases. Titin antibodies occurred more frequently in MGT, especially in MG with epithelial predominant-thymoma, and were correlated with the severity of disease. The levels of titin antibodies were reduced 6 months after thymectomy. The specificity of titin antibodies for the detection of thymoma was higher than that of CT examination in MG with thymoma. These results suggest that titin antibodies could be useful in both diagnosis and follow-up of MG patients with thymoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15316806     DOI: 10.1007/s00415-004-0479-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  20 in total

1.  Titin, thymoma, and myasthenia gravis.

Authors:  J A Aarli
Journal:  Arch Neurol       Date:  2001-06

2.  Anti-titin antibodies are not associated with a specific thymoma histology.

Authors:  R Voltz; W Albrich; R Hohlfeld; D Nagel; M Wick; T Kirchner; N Sommer; I Illa; H Kaminski; F Schumm
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

3.  Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients.

Authors:  A M Yamamoto; P Gajdos; B Eymard; C Tranchant; J M Warter; L Gomez; C Bourquin; J F Bach; H J Garchon
Journal:  Arch Neurol       Date:  2001-06

4.  Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor.

Authors:  R D Voltz; W C Albrich; A Nägele; F Schumm; M Wick; A Freiburg; M Gautel; H T Thaler; J Aarli; T Kirchner; R Hohlfeld
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

Review 5.  Non-receptor striated muscle antibodies in sera from patients with myasthenia gravis.

Authors:  J A Aarli; P R Flood; N E Gilhus; H Hofstad; R Matre
Journal:  Monogr Allergy       Date:  1988

6.  The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.

Authors:  F Romi; G O Skeie; J A Aarli; N E Gilhus
Journal:  Arch Neurol       Date:  2000-11

7.  Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis.

Authors:  A Marx; A Wilisch; A Schultz; A Greiner; B Magi; V Pallini; B Schalke; K Toyka; W Nix; T Kirchner; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

8.  Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin.

Authors:  M Gautel; A Lakey; D P Barlow; Z Holmes; S Scales; K Leonard; S Labeit; A Mygland; N E Gilhus; J A Aarli
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

9.  Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.

Authors:  C L Williams; J E Hay; T W Huiatt; V A Lennon
Journal:  Lab Invest       Date:  1992-03       Impact factor: 5.662

10.  Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.

Authors:  Fredrik Romi; Lars Bø; Geir Olve Skeie; Andreas Myking; Johan A Aarli; Nils Erik Gilhus
Journal:  J Neuroimmunol       Date:  2002-07       Impact factor: 3.478

View more
  11 in total

Review 1.  Stretch your heart-but not too far: The role of titin mutations in dilated cardiomyopathy.

Authors:  Eric J Stöhr; Hiroo Takayama; Giovanni Ferrari
Journal:  J Thorac Cardiovasc Surg       Date:  2018-03-12       Impact factor: 5.209

2.  Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis.

Authors:  Isabell Cordts; Nicolas Bodart; Kathi Hartmann; Katerina Karagiorgou; John S Tzartos; Lin Mei; Jens Reimann; Philip Van Damme; Michael H Rivner; Alain Vigneron; Joachim Weis; Jörg B Schulz; Socrates J Tzartos; Kristl G Claeys
Journal:  J Neurol       Date:  2017-05-17       Impact factor: 4.849

3.  Three types of striational antibodies in myasthenia gravis.

Authors:  Shigeaki Suzuki; Kimiaki Utsugisawa; Yuriko Nagane; Norihiro Suzuki
Journal:  Autoimmune Dis       Date:  2011-07-17

4.  Human thymic epithelial primary cells produce exosomes carrying tissue-restricted antigens.

Authors:  Gabriel Skogberg; Vanja Lundberg; Martin Berglund; Judith Gudmundsdottir; Esbjörn Telemo; Susanne Lindgren; Olov Ekwall
Journal:  Immunol Cell Biol       Date:  2015-03-17       Impact factor: 5.126

5.  Prognostic Analysis of Thymoma-Associated Myasthenia Gravis (MG) in Chinese Patients and Its Implication of MG Management: Experiences from a Tertiary Hospital.

Authors:  Di Chen; Yuyao Peng; Zhibin Li; Wanlin Jin; Ran Zhou; Yi Li; Qiushuang Xu; Huan Yang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-04-14       Impact factor: 2.570

6.  Paraneoplastic pemphigus: a clinical, laboratorial, and therapeutic overview.

Authors:  Celina Wakisaka Maruta; Denise Miyamoto; Valeria Aoki; Ricardo Gomes Ribeiro de Carvalho; Breno Medeiros Cunha; Claudia Giuli Santi
Journal:  An Bras Dermatol       Date:  2019-10-17       Impact factor: 1.896

Review 7.  Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management.

Authors:  Konstantinos Lazaridis; Socrates J Tzartos
Journal:  Front Neurol       Date:  2020-11-30       Impact factor: 4.003

8.  Incidence of thymoma in myasthenia gravis: a systematic review.

Authors:  Zhi-Feng Mao; Xue-An Mo; Chao Qin; Yong-Rong Lai; Maree L Hackett
Journal:  J Clin Neurol       Date:  2012-09-27       Impact factor: 3.077

Review 9.  Exosomes in the Thymus: Antigen Transfer and Vesicles.

Authors:  Gabriel Skogberg; Esbjörn Telemo; Olov Ekwall
Journal:  Front Immunol       Date:  2015-07-20       Impact factor: 7.561

Review 10.  Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics.

Authors:  Konstantinos Lazaridis; Socrates J Tzartos
Journal:  Front Immunol       Date:  2020-02-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.